Sowell Financial Services’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $329K | Sell |
8,575
-1,008
| -11% | -$38.7K | 0.01% | 748 |
|
2025
Q1 | $371K | Sell |
9,583
-1,577
| -14% | -$61.1K | 0.02% | 676 |
|
2024
Q4 | $377K | Buy |
11,160
+1,029
| +10% | +$34.8K | 0.02% | 439 |
|
2024
Q3 | $419K | Sell |
10,131
-2,978
| -23% | -$123K | 0.02% | 461 |
|
2024
Q2 | $510K | Sell |
13,109
-124
| -0.9% | -$4.82K | 0.02% | 434 |
|
2024
Q1 | $573K | Buy |
13,233
+472
| +4% | +$20.4K | 0.03% | 433 |
|
2023
Q4 | $477K | Sell |
12,761
-298
| -2% | -$11.1K | 0.03% | 435 |
|
2023
Q3 | $478K | Sell |
13,059
-23,725
| -64% | -$868K | 0.03% | 405 |
|
2023
Q2 | $1.32M | Buy |
36,784
+23,492
| +177% | +$840K | 0.07% | 303 |
|
2023
Q1 | $473K | Sell |
13,292
-29,426
| -69% | -$1.05M | 0.04% | 441 |
|
2022
Q4 | $1.51M | Buy |
42,718
+28,649
| +204% | +$1.01M | 0.1% | 236 |
|
2022
Q3 | $416K | Buy |
+14,069
| New | +$416K | 0.04% | 339 |
|
2021
Q3 | – | Sell |
-11,915
| Closed | -$601K | – | 506 |
|
2021
Q2 | $601K | Sell |
11,915
-363
| -3% | -$18.3K | 0.04% | 396 |
|
2021
Q1 | $582K | Buy |
12,278
+4,711
| +62% | +$223K | 0.02% | 591 |
|
2020
Q4 | $348K | Buy |
7,567
+38
| +0.5% | +$1.75K | 0.01% | 637 |
|
2020
Q3 | $354K | Sell |
7,529
-1,548
| -17% | -$72.8K | 0.02% | 560 |
|
2020
Q2 | $463K | Sell |
9,077
-3,016
| -25% | -$154K | 0.03% | 478 |
|
2020
Q1 | $573K | Sell |
12,093
-561
| -4% | -$26.6K | 0.04% | 364 |
|
2019
Q4 | $743K | Buy |
12,654
+2,504
| +25% | +$147K | 0.06% | 335 |
|
2019
Q3 | $541K | Buy |
+10,150
| New | +$541K | 0.04% | 402 |
|
2017
Q1 | – | Sell |
-1,701
| Closed | -$86K | – | 386 |
|
2016
Q4 | $86K | Buy |
+1,701
| New | +$86K | 0.03% | 284 |
|